BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26242673)

  • 21. Are the favorable outcomes of splenectomy predictable inpatients with idiopathic thrombocytopenic purpura (ITP)?
    Tsereteli Z; Smith CD; Branum GD; Galloway JR; Amerson RJ; Chakaraborty H; Hunter JG
    Surg Endosc; 2001 Dec; 15(12):1386-9. PubMed ID: 11965451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experience.
    Pavkovic M; Trpkovska-Terzieva S; Sotirova T; Latifi A; Cevreska L; Stojanovic A
    Prilozi; 2012; 33(1):121-33. PubMed ID: 22952099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura: study of clinical and laboratory data.
    Balagué C; Vela S; Targarona EM; Gich IJ; Muñiz E; D'Ambra A; Pey A; Monllau V; Ascaso E; Martinez C; Garriga J; Trias M
    Surg Endosc; 2006 Aug; 20(8):1208-13. PubMed ID: 16865623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
    González-López TJ; Pascual C; Álvarez-Román MT; Fernández-Fuertes F; Sánchez-González B; Caparrós I; Jarque I; Mingot-Castellano ME; Hernández-Rivas JA; Martín-Salces M; Solán L; Beneit P; Jiménez R; Bernat S; Andrade MM; Cortés M; Cortti MJ; Pérez-Crespo S; Gómez-Núñez M; Olivera PE; Pérez-Rus G; Martínez-Robles V; Alonso R; Fernández-Rodríguez A; Arratibel MC; Perera M; Fernández-Miñano C; Fuertes-Palacio MA; Vázquez-Paganini JA; Gutierrez-Jomarrón I; Valcarce I; de Cabo E; Sainz A; Fisac R; Aguilar C; Paz Martínez-Badas M; Peñarrubia MJ; Calbacho M; de Cos C; González-Silva M; Coria E; Alonso A; Casaus A; Luaña A; Galán P; Fernández-Canal C; Garcia-Frade J; González-Porras JR
    Am J Hematol; 2015 Mar; 90(3):E40-3. PubMed ID: 25400215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.
    Mahévas M; Gerfaud-Valentin M; Moulis G; Terriou L; Audia S; Guenin S; Le Guenno G; Salles G; Lambotte O; Limal N; Viallard JF; Cheze S; Tomowiak C; Royer B; Neel A; Debouverie O; Hot A; Durieu I; Perlat A; Cliquennois M; Deteix C; Michel M; Godeau B
    Blood; 2016 Sep; 128(12):1625-30. PubMed ID: 27354722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura.
    Duperier T; Brody F; Felsher J; Walsh RM; Rosen M; Ponsky J
    Arch Surg; 2004 Jan; 139(1):61-6; discussion 66. PubMed ID: 14718278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on responses after splenectomy for idiopathic thrombocytopenic purpura patients, Kathmandu, Nepal.
    Shrestha S; Pradhan GB; Shrestha R; Singh R
    Nepal Med Coll J; 2012 Dec; 14(4):328-30. PubMed ID: 24579545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.
    Palandri F; Polverelli N; Catani L; Sollazzo D; Romano M; Levorato M; Vianelli N
    Am J Hematol; 2014 Nov; 89(11):1047-50. PubMed ID: 25103500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reemergence of Splenectomy for ITP Second-line Treatment?
    Chater C; Terriou L; Duhamel A; Launay D; Chambon JP; Pruvot FR; Rogosnitzky M; Zerbib P
    Ann Surg; 2016 Nov; 264(5):772-777. PubMed ID: 27741009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of splenectomy in chronic idiopathic thrombocytopenic purpura.
    Srinivasan S; Sabapathy K; Bharadwaj TP; Sethuraman S
    J Assoc Physicians India; 2003 Feb; 51():159-62. PubMed ID: 12725258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and Therapy of Immune thrombocytopenia].
    Matzdorff A; Wörmann B
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1076-1081. PubMed ID: 30060276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose dexamethasone for splenectomy in patients with idiopathic thrombocytopenic purpura.
    Bulvik S; Winder A; Ben-Tal O; Szold A; Eldor A
    Haemostasis; 1998; 28(5):256-9. PubMed ID: 10420075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors of response to laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura.
    Kwon HC; Moon CH; Cho YR; Kim MC; Kim KH; Han JY; Lee YH; Oh SY; Kim SH; Kim JS; Kim HJ
    J Korean Med Sci; 2005 Jun; 20(3):417-20. PubMed ID: 15953862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic splenectomy is a better treatment for adult ITP than steroids--it should be used earlier in patient management. Conclusions of a ten-year follow-up study.
    Khan LR; Nixon SJ
    Surgeon; 2007 Feb; 5(1):3-4, 6-8. PubMed ID: 17313122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia.
    Kaya E; Erkurt MA; Aydogdu I; Kuku I; Ozhan O; Oner RI; Ulutas O
    Med Princ Pract; 2007; 16(2):100-6. PubMed ID: 17303943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura: A Case Series.
    Kowalczyk M; Rubinstein PG; Aboulafia DM
    J Int Assoc Provid AIDS Care; 2015; 14(3):211-6. PubMed ID: 25504472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
    Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN
    Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.